# Registration and reporting of clinical trials affiliated with California universities and with primary completion date from 2014 to 2017

**Authors:** Mario Malički, Vladislav Nachev, Susanne Wieschowski, Nicole Hildebrand, Stefanie Gestrich, Samruddhi Yerunkar, Emmanuel Zavalis, Benjamin Gregory Carlisle, Delwen L. Franzen, Maia Salholz-Hillel, Steven N. Goodman, Daniel Strech

PMC · DOI: 10.1186/s13063-025-09270-2 · Trials · 2025-12-01

## TL;DR

This study examined how well clinical trials affiliated with California universities reported their results publicly from 2014 to 2017.

## Contribution

The study provides empirical data on registration and reporting compliance of clinical trials affiliated with California universities.

## Key findings

- Only 58% of trials reported results within 2 years of completion.
- 77% of journal publications were open access.
- Only 2% of legally required trials were overdue for reporting.

## Abstract

Public information on US clinical trials is shared through the ClinicalTrials.gov registry. This study’s goal was to determine prospective registration, results reporting, trial registration number reporting, and publication accessibility status for trials with primary completion dates from 2014 to 2017 affiliated with seven California universities.

We identified trials with investigators, sponsors, or responsible parties affiliated with seven California universities and searched for their results publications manually. We then used semi-automatic methods to determine prospective registration, summary results reporting in a registry, publication status, and reporting of registration numbers in the abstract and the full text of manuscripts.

We identified 1091 unique trials. Most trials were single-center (n = 752, 69%) and had a median of 50 participants (IQR 21 to 150). Overall, 64% of trials (n = 698) were prospectively registered, 46% (n = 500) had summary results reported in the registry, 69% (n = 750) had results published as articles, and an additional 3% (n = 36) as abstracts or posters. Results reporting (summary, articles, abstracts or posters) occurred for 58% of trials (n = 637) within 2 years, and for 81% (n = 888) within 5 years of the study’s primary completion date. Of journal publications, 77% (n = 579) were open access publications, 37% (n = 276) had trial registration numbers listed in their abstract, and 45% (n = 336) in the manuscript. Only 92 (8%) of these trials were legally required to report results, and only 2 (2%) of those were overdue and under the primary responsibility of a California university to report.

Almost one fifth of clinical trials with primary completion dates from 2014 to 2017 with investigators, sponsors or responsible parties affiliated with seven California biomedical research universities lacked any results reporting 5 years after their primary completion, and only 58% reported results within 2 years. Even though a large majority of these trials were completed before US legal mandates for reporting, there was an ethical requirement that the burden to research participants should be commensurate with the scientific value of the research. Research has no public scientific value if its results are not reported.

The online version contains supplementary material available at 10.1186/s13063-025-09270-2.

## Full-text entities

- **Chemicals:** gold (MESH:D006046)
- **Species:** Homo sapiens (human, species) [taxon 9606]

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12771935/full.md

## Figures

1 figure with captions in the complete paper: https://tomesphere.com/paper/PMC12771935/full.md

## References

9 references — full list in the complete paper: https://tomesphere.com/paper/PMC12771935/full.md

---
Source: https://tomesphere.com/paper/PMC12771935